Opportunity Information: Apply for PAR 06 222
Apply for PAR 06 222
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Mentored Patient Oriented Research Award to Promote Diversity (K23)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398 Cancer Research Manpower.
- This funding opportunity was created on Dec 19, 2008 and posted on Mar 9, 2006.
- Applicants must submit their applications by Jan 7, 2009 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education For profit organizations other than small businesses Private institutions of higher education.
- Foreign institutions are not eligible to apply. Eligible institutions must also have active biomedical research programs in oncology, including clinical trials with adequate numbers of highly trained faculty in clinical and biomedical science areas as they relate to cancer. They must also demonstrate a commitment to the development of the research careers of junior underrepresented minority health professionals in clinical oncology. Foreign institutions and organizations are not eligible to apply for this award.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Mentored Patient Oriented Research Award to Promote Diversity (K23) is a National Cancer Institute (NCI) career development grant designed to build a stronger and more diverse workforce of clinicians who do patient-oriented cancer research. Run through the NCI Comprehensive Minority Biomedical Branch (CMBB) within the Office of Centers, Training and Resources (OCTR), the program focuses on supporting health professional doctorate holders who are committed to translating advances in biomedical science into clinical settings. The larger purpose is to increase representation of investigators from groups historically underrepresented in health-related science so that the field draws from the broadest possible pool of talent while accelerating progress in cancer diagnosis, treatment, and risk prediction.
This K23 specifically supports mentored, patient-oriented research, meaning research conducted with human subjects (or using human materials linked to clinical outcomes) that is grounded in direct patient care questions and clinical translation. The award is meant for individuals who have already completed their clinical training, including specialty training and, when relevant, subspecialty training, and who can show both clinical competence and a clear long-term intention to pursue a research career in clinical oncology. The program emphasizes structured career development: a supervised research experience paired with training activities that can include formal coursework or other didactic study, all built around a coherent plan to develop the candidate into an independent patient-oriented cancer researcher.
Eligibility is centered on both professional background and the program's diversity mission. Candidates must hold a health professional doctoral degree such as an M.D., D.D.S., D.O., O.D., D.V.M., D.N.Sc., N.D. (Doctor of Naturopathy), or Pharm.D. They must also come from groups shown to be underrepresented in science, including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds (with the detailed definitions and documentation requirements described in the full funding announcement). In addition, candidates must be U.S. citizens, non-citizen nationals, or lawful permanent residents.
Applications are submitted by a U.S.-based sponsoring institution on behalf of the candidate. Eligible applicant organizations include domestic public or private institutions such as universities, colleges, hospitals, laboratories, and other for-profit or non-profit organizations. Foreign institutions are explicitly not eligible. Beyond being domestic, the sponsoring institution is expected to have an active oncology-focused biomedical research environment, including clinical trials, with a sufficient number of highly trained faculty across clinical and biomedical sciences relevant to cancer. The institution must also be able to demonstrate a real commitment to developing the research careers of junior underrepresented minority health professionals in clinical oncology, which typically translates into having the mentorship, infrastructure, patient access, and protected time needed for the awardee to succeed.
In terms of support, the mechanism provides up to $75,000 per year for salary plus benefits, and up to $30,000 per year for research development support. The project period lasts 3 to 5 years and is structured as a mentored experience combining career development and a patient-oriented research project. A core requirement is effort commitment: the candidate must devote at least 75 percent of full-time professional effort to patient-oriented research and career development activities, which is intended to ensure sufficient protected time for training and productivity. The candidate and mentoring team are responsible for the planning, direction, and execution of the proposed career development plan and the associated research.
Several administrative and policy constraints are highlighted in the announcement. K23 awards under this program are not renewable and cannot be transferred to a different principal investigator. Prior support may affect eligibility, so applicants need to check the full announcement for restrictions related to previous NIH or comparable funding. The applicant also may not apply concurrently for, or have pending, another NIH career development award at the same time. The number of awards and total dollars ultimately made available depend on application quality, the peer review process, program priorities, and available funds. The solicitation allowed multiple receipt dates (rather than a single deadline) during its active period, accepted up to two application revisions, and was ultimately time-bounded as an archived opportunity (Funding Opportunity Number PAR-06-222; CFDA 93.398, Cancer Research Manpower), with no cost sharing required.
Overall, this opportunity is best understood as a mentored bridge for clinically trained professionals from underrepresented backgrounds who want to build a long-term, independent career in patient-oriented cancer research. It provides salary support, research development funds, structured mentorship, and protected time, all aimed at strengthening the pipeline of diverse clinical investigators who can translate scientific discoveries into improvements in cancer care.
Frequently Asked Questions (FAQs)
What is the Mentored Patient Oriented Research Award to Promote Diversity (K23)?
The Mentored Patient Oriented Research Award to Promote Diversity (K23) is a National Cancer Institute (NCI) career development grant intended to build a stronger and more diverse workforce of clinicians who conduct patient-oriented cancer research.
Which part of NCI runs this K23 diversity program?
The program is run through the NCI Comprehensive Minority Biomedical Branch (CMBB) within the Office of Centers, Training and Resources (OCTR).
What is the main goal of this funding opportunity?
The larger purpose is to increase representation of investigators from groups historically underrepresented in health-related science, while helping accelerate progress in cancer diagnosis, treatment, and risk prediction through clinically grounded research.
What does "patient-oriented research" mean in this program?
In this K23, patient-oriented research means research conducted with human subjects, or research using human materials that are linked to clinical outcomes. The research is expected to be grounded in direct patient care questions and focused on clinical translation.
What kind of career stage is this K23 intended for?
This award is meant for individuals who have completed their clinical training, including specialty training and, when relevant, subspecialty training, and who can show clinical competence and a clear long-term intention to pursue a research career in clinical oncology.
Is the award mentored, and what does the mentoring structure involve?
Yes. The award supports a mentored experience that combines a supervised research project with a structured career development plan. Training activities may include formal coursework or other didactic study, organized into a coherent plan to develop the candidate into an independent patient-oriented cancer researcher.
What degrees are eligible for candidates?
Candidates must hold a health professional doctoral degree such as an M.D., D.D.S., D.O., O.D., D.V.M., D.N.Sc., N.D. (Doctor of Naturopathy), or Pharm.D.
Who is the program trying to support from a diversity perspective?
Eligibility is tied to the program's diversity mission and includes individuals from groups shown to be underrepresented in science, including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. The detailed definitions and documentation requirements are described in the full funding announcement.
What citizenship or residency status is required?
Candidates must be U.S. citizens, non-citizen nationals, or lawful permanent residents.
Who submits the application: the individual candidate or the institution?
Applications are submitted by a U.S.-based sponsoring institution on behalf of the candidate.
What types of institutions can serve as the sponsoring applicant organization?
Eligible applicant organizations include domestic public or private institutions such as universities, colleges, hospitals, laboratories, and other for-profit or non-profit organizations.
Are foreign institutions eligible to apply?
No. Foreign institutions are explicitly not eligible.
What kind of research environment is the sponsoring institution expected to have?
The sponsoring institution is expected to have an active oncology-focused biomedical research environment, including clinical trials, and a sufficient number of highly trained faculty across clinical and biomedical sciences relevant to cancer.
What commitment must the institution demonstrate for the candidate's career development?
The institution must be able to demonstrate a real commitment to developing the research careers of junior underrepresented minority health professionals in clinical oncology, generally reflected through mentorship, infrastructure, patient access, and protected time needed for the awardee to succeed.
How much salary support is provided?
The mechanism provides up to $75,000 per year for salary plus benefits.
How much funding is provided for research development activities?
The award provides up to $30,000 per year for research development support.
How long is the project period?
The project period lasts 3 to 5 years.
What is the minimum required effort commitment for the candidate?
The candidate must devote at least 75 percent of full-time professional effort to patient-oriented research and career development activities, to ensure sufficient protected time for training and productivity.
Who is responsible for planning and carrying out the career development plan and research?
The candidate and mentoring team are responsible for the planning, direction, and execution of the proposed career development plan and the associated patient-oriented research project.
Is this K23 award renewable?
No. K23 awards under this program are not renewable.
Can this award be transferred to a different principal investigator?
No. The award cannot be transferred to a different principal investigator.
Can a candidate apply if they have had prior NIH or comparable support?
Prior support may affect eligibility. Applicants are expected to check the full funding announcement for restrictions related to previous NIH or comparable funding.
Can a candidate apply for this K23 while another NIH career development award application is pending?
No. The applicant may not apply concurrently for, or have pending, another NIH career development award at the same time.
Is cost sharing required?
No cost sharing is required.
How are award decisions determined?
The number of awards and total dollars made available depend on application quality, peer review outcomes, program priorities, and available funds.
Were there multiple submission dates for this opportunity?
Yes. The solicitation allowed multiple receipt dates during its active period rather than a single deadline.
How many application revisions were allowed?
Up to two application revisions were accepted.
Is this funding opportunity still active?
The opportunity is described as time-bounded and archived (Funding Opportunity Number PAR-06-222; CFDA 93.398, Cancer Research Manpower).
Who is this opportunity best suited for?
This opportunity is best understood as a mentored bridge for clinically trained professionals from underrepresented backgrounds who want to build a long-term, independent career in patient-oriented cancer research, supported through mentorship, protected time, salary support, and research development funds.
Browse more opportunities from the same category: Education Health
Next opportunity: Mentored Research Scientist Development Award (K01)
Previous opportunity: NCI Mentored Clinical Scientist Award to Promote Diversity (K08)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 06 222
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 06 222) also looked into and applied for these:
| Funding Opportunity |
|---|
| Building Translational Research in Integrative Behavioral Science (R24) Apply for PAR 06 357 Funding Number: PAR 06 357 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Cancer Prevention, Control, Behavioral, and Population Sciences Career Development Award (K07) Apply for PAR 06 381 Funding Number: PAR 06 381 Agency: National Institutes of Health Category: Education Health Funding Amount: $105,000 |
| Paul Calabresi Career Development Award For Clinical Oncology (K12) Apply for PAR 06 449 Funding Number: PAR 06 449 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award (K22) Apply for PAR 06 455 Funding Number: PAR 06 455 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (F31) Apply for PA 07 002 Funding Number: PA 07 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership (P20) Apply for PAR 07 230 Funding Number: PAR 07 230 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 07 346 Funding Number: PAR 07 346 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS International Training and Research Program (D43) Apply for PAR 07 348 Funding Number: PAR 07 348 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| 2009 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 09 011 Funding Number: RFA DA 09 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Pre Application for the 2009 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 09 044 Funding Number: PAR 09 044 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative and Applied Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 09 004 Funding Number: RFA CA 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Innovative and Applied Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 09 005 Funding Number: RFA CA 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Application and Use of Transformative Emerging Technologies in Cancer Research (R21) Apply for RFA CA 09 006 Funding Number: RFA CA 09 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Application and Use of Transformative Emerging Technologies in Cancer Research (R33) Apply for RFA CA 09 007 Funding Number: RFA CA 09 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 09 008 Funding Number: RFA CA 09 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Apply for PAR 09 050 Funding Number: PAR 09 050 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Patient Oriented Research Career Development Award to Promote Diversity (K23) Apply for PAR 09 051 Funding Number: PAR 09 051 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Apply for PAR 09 052 Funding Number: PAR 09 052 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanism for Time Sensitive Research Opportunities (R03) Apply for PAR 06 249 Funding Number: PAR 06 249 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 09 021 Funding Number: RFA DA 09 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $25,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 06 222", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.